UNSPSC 51242103: Naphazoline/phenylephrine/pyrilamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class NT900. This VA Drug Class (NT900) classifies this compound as belonging to the group NASAL AND THROAT, TOPICAL, OTHER.

UNSPSC 51242103 Naphazoline/phenylephrine/pyrilamine is a Commodity code encompassing decongestant and antihistamine combination products for procurement by state and local government healthcare facilities. State and local health departments and purchasing cooperatives acquire these over-the-counter ophthalmic and nasal decongestant formulations for distribution across government clinics, correctional facilities, emergency departments, and other public health settings. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents the primary issuing body active under this code; cooperative purchasing vehicles like MMCAP allow multiple states and localities to aggregate volume and negotiate standardized pricing for pharmaceutical products across their member jurisdictions.

The Minnesota Department of Administration's Office of State Procurement issued an RFP (Solicitation S1070000015802) on January 20, 2026, with a response deadline of March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products including naphazoline/phenylephrine/pyrilamine formulations. The solicitation requires vendors to supply products with specific National Drug Codes (NDC) through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—with all products available by May 15, 2026 and contract effectiveness July 1, 2026. Vendors must certify compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), maintain relationships with at least two of the three authorized wholesalers with chargeback systems in place, and submit detailed product information including NDC codes, SKUs, UPCs, generic descriptions, strength, dosage form, and packaging configurations in designated Excel-to-CSV format. The evaluation weights price competitiveness at 75 percent, with remaining points allocated to fixed pricing, administrative fee compliance, EDI capability, and acceptance of a 3 percent administrative fee on all contract purchases. The RFP covers Minnesota and Oregon with a two-year initial contract term and optional extensions, with no specific set-aside restrictions disclosed in available documentation.